A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD1446

ER Fast, 90mg, p.o. capsule

DRUG

AZD1446

ER Moderate, 90mg, p.o. capsule

DRUG

AZD1446

ER Slow, 90mg, p.o. capsule

DRUG

AZD1446

MR

DRUG

AZD1446

IR, 90 mg p.o. capsule

DRUG

Placebo

IR

DRUG

Placebo

ER/MR

Trial Locations (2)

Unknown

Research Site, Luleå

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY